Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Harte Hanks (HHS) Capital Expenditures (2016 - 2025)

Harte Hanks has reported Capital Expenditures over the past 16 years, most recently at $2.2 million for Q4 2025.

Quarterly Capital Expenditures fell 7.25% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Dec 2025, down 26.4% year-over-year, with the annual reading at $2.8 million for FY2025, 26.4% down from the prior year.
Capital Expenditures was $2.2 million for Q4 2025 at Harte Hanks, up from -$64000.0 in the prior quarter.
Over five years, Capital Expenditures peaked at $2.3 million in Q4 2024 and troughed at -$935000.0 in Q2 2021.
The 5-year median for Capital Expenditures is $554000.0 (2023), against an average of $663150.0.
Year-over-year, Capital Expenditures plummeted 242.19% in 2022 and then skyrocketed 3680.65% in 2024.
A 5-year view of Capital Expenditures shows it stood at $237000.0 in 2021, then plummeted by 242.19% to -$337000.0 in 2022, then skyrocketed by 118.4% to $62000.0 in 2023, then skyrocketed by 3680.65% to $2.3 million in 2024, then dropped by 7.25% to $2.2 million in 2025.
Per Business Quant, the three most recent readings for HHS's Capital Expenditures are $2.2 million (Q4 2025), -$64000.0 (Q3 2025), and $542000.0 (Q2 2025).